These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1352745)

  • 21. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.
    Tausk FA; McCutchan A; Spechko P; Schreiber RD; Gigli I
    J Clin Invest; 1986 Oct; 78(4):977-82. PubMed ID: 2944915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative variations of the C3b/C4b receptor (CR1) in human erythrocytes are controlled by genes within the regulator of complement activation (RCA) gene cluster.
    Rodriguez de Cordoba S; Rubinstein P
    J Exp Med; 1986 Oct; 164(4):1274-83. PubMed ID: 2944984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele.
    Wong WW; Cahill JM; Rosen MD; Kennedy CA; Bonaccio ET; Morris MJ; Wilson JG; Klickstein LB; Fearon DT
    J Exp Med; 1989 Mar; 169(3):847-63. PubMed ID: 2564414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms.
    Cohen JH; Atkinson JP; Klickstein LB; Oudin S; Subramanian VB; Moulds JM
    Mol Immunol; 1999; 36(13-14):819-25. PubMed ID: 10698335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficiency of erythrocyte C3b receptor (CR1) in AIDS and AIDS-related syndromes.
    Tausk FA; McCutchan JA; Schreiber RD; Spechko P; Gigli I
    Biosci Rep; 1986 Jan; 6(1):81-6. PubMed ID: 2938642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.
    Michelsen B; Lernmark A
    J Clin Invest; 1987 Apr; 79(4):1144-52. PubMed ID: 2881947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome.
    Wang FS; Chu FL; Jin L; Li YG; Zhang Z; Xu D; Shi M; Wu H; Moulds JM
    Clin Exp Immunol; 2005 Jan; 139(1):112-9. PubMed ID: 15606620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations.
    Herrera AH; Xiang L; Martin SG; Lewis J; Wilson JG
    Clin Immunol Immunopathol; 1998 May; 87(2):176-83. PubMed ID: 9614933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism.
    Holers VM; Chaplin DD; Leykam JF; Gruner BA; Kumar V; Atkinson JP
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2459-63. PubMed ID: 3031685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3' untranslated regions of the CR1 gene.
    Cockburn IA; Rowe JA
    Int J Immunogenet; 2006 Feb; 33(1):17-20. PubMed ID: 16426237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35): vesiculation and/or proteolysis?
    Dervillez X; Oudin S; Libyh MT; Tabary T; Reveil B; Philbert F; Bougy F; Pluot M; Cohen JH
    Immunopharmacology; 1997 Dec; 38(1-2):129-40. PubMed ID: 9476124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of multiple restriction fragment length polymorphisms of the gene for the human complement receptor type I. Duplication of genomic sequences occurs in association with a high molecular mass receptor allotype.
    Wong WW; Kennedy CA; Bonaccio ET; Wilson JG; Klickstein LB; Weis JH; Fearon DT
    J Exp Med; 1986 Nov; 164(5):1531-46. PubMed ID: 2877046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1.
    Satoh H; Yokota E; Tokiyama K; Kawaguchi T; Niho Y
    Ann Rheum Dis; 1991 Nov; 50(11):765-8. PubMed ID: 1685310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and structural polymorphism of complement receptor 1 in normal Indian subjects.
    Katyal M; Sivasankar B; Ayub S; Das N
    Immunol Lett; 2003 Oct; 89(2-3):93-8. PubMed ID: 14556965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal distribution of complement C3b receptor (CR1) numbers on erythrocytes in blood donors: low levels are associated with HLA-B27.
    Thomsen BS; Jacobsen SE; Nielsen H; Jakobsen BK; Sørensen H
    Complement; 1986; 3(2):79-87. PubMed ID: 2945696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
    Forslid J; Hed J; Stendahl O
    Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases.
    Miyaike J; Iwasaki Y; Takahashi A; Shimomura H; Taniguchi H; Koide N; Matsuura K; Ogura T; Tobe K; Tsuji T
    Gut; 2002 Oct; 51(4):591-6. PubMed ID: 12235086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.
    Moldenhauer F; Botto M; Walport MJ
    Clin Exp Immunol; 1988 Apr; 72(1):74-8. PubMed ID: 2899464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5430-4. PubMed ID: 6225118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decay-accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans.
    Rey-Campos J; Rubinstein P; Rodriguez de Cordoba S
    J Exp Med; 1987 Jul; 166(1):246-52. PubMed ID: 2439634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.